You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,921,843


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,921,843
Title: Contraception system and method
Abstract:A method of contraception is disclosed which comprises a two-stage protocol. In the first stage, an estrogenic compound in a first composition is administered daily as the sole contraceptively active substance to a human female from about Day 2 to about Day 7 of her menstrual cycle, where Day 1 is the first day of menses. The second stage of the protocol occurs immediately thereafter during which at least one follow-up composition containing a progestin is administered daily to the same human female. The follow-up composition can contain a progestin as the sole contraceptively active ingredient, or can contain a combination of an estrogenic compound with a progestin in different weight ratios. A drug delivery system containing daily dosage units is also described.
Inventor(s): Pasquale; Samuel A. (Basking Ridge, NJ)
Assignee:
Application Number:07/260,447
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Delivery; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,921,843

Introduction

Understanding the scope and claims of a patent is crucial for determining its validity, enforcing intellectual property rights, and navigating the patent landscape. This article will delve into the details of United States Patent 4,921,843, focusing on its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 4,921,843, titled "Contraceptive Composition and Method of Use," was granted for a specific contraceptive system. Here, we will break down the key components of this patent.

Claim Construction

Claim construction is a critical step in patent analysis, as it defines the scope of the invention. The court's role in claim construction is to interpret the meaning of the claims, which is a question of law[1].

Literal Infringement

To prove literal infringement, the accused product must contain every element and limitation of the patent claims. For example, in the case of a contraceptive system like the one in Patent 4,921,843, the claims might specify a particular sequence of dosages and the types of active ingredients used.

  • Claim Elements: Each claim in the patent outlines specific elements that must be present in the accused product. For instance, Claim 1 might describe a method of contraception involving a sequence of pills with specific dosages of estrogenic and progestin compounds[1].

  • Sequential Dosage: The patent specification often emphasizes the importance of the sequence in which the pills are taken. This sequence is a key limitation that must be met for the claim to be infringed[1].

Scope of the Patent

The scope of a patent is defined by its claims, which set the boundaries of what is protected.

Claim 1 Analysis

Claim 1 typically sets the foundation for the invention. In the case of Patent 4,921,843, it might read something like:

  • "A method of contraception comprising an initial dosage of an estrogenic compound followed by a sequence of progestin dosages."

  • Key Limitations: The claim specifies the type of compounds, the sequence of administration, and the duration of the treatment. These limitations are crucial in determining what falls within the scope of the patent[1].

Doctrine of Equivalents

In addition to literal infringement, the doctrine of equivalents allows for infringement to be found if the accused product performs substantially the same function in substantially the same way to achieve substantially the same result as the claimed invention[1].

Application to Patent 4,921,843

If a generic version of the contraceptive system uses a slightly different sequence or dosage but achieves the same contraceptive effect, it might be considered an equivalent and thus infringe the patent under the doctrine of equivalents.

Patent Landscape Analysis

Understanding the broader patent landscape is essential for strategic decision-making.

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, which can be used to analyze the scope and coverage of patents like 4,921,843. This dataset helps in identifying trends and patterns in patent claims, which can inform strategies for patent protection and enforcement[3].

Claim Coverage Matrix

A Claim Coverage Matrix, as used in patent analytics, categorizes patents by claims and scope concepts. This tool helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. For Patent 4,921,843, such a matrix would highlight the specific claims and their coverage, aiding in the management of the patent portfolio[5].

Patent Search and Public Resources

Utilizing public resources is vital for conducting thorough patent searches and analyzing the patent landscape.

Patent Public Search

The USPTO's Patent Public Search tool allows users to search for existing patents and published patent applications. This tool can be used to find prior art related to Patent 4,921,843 and to understand how it fits into the broader landscape of contraceptive systems[4].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This can help in identifying similar patents and understanding the global implications of Patent 4,921,843[4].

Stakeholder Engagement and Small Claims Courts

Engaging with stakeholders and considering the feasibility of small claims courts can also impact the patent landscape.

Consultative Groups and Public Comments

Studies like the one conducted by ACUS on small claims patent courts involve extensive stakeholder engagement. This includes public comments and input from academic experts and legal practitioners, which can shape the future of patent litigation and enforcement[2].

Key Takeaways

  • Claim Construction: Accurate interpretation of patent claims is crucial for determining infringement.
  • Scope of the Patent: The claims define the boundaries of what is protected under the patent.
  • Doctrine of Equivalents: This doctrine allows for infringement to be found if the accused product is substantially equivalent to the claimed invention.
  • Patent Landscape Analysis: Tools like the Patent Claims Research Dataset and Claim Coverage Matrix are essential for strategic patent management.
  • Public Resources: Utilizing tools like the Patent Public Search and Global Dossier can provide comprehensive insights into the patent landscape.

FAQs

Q: What is the importance of claim construction in patent law? A: Claim construction is critical as it defines the scope of the invention and determines what is protected under the patent.

Q: How does the doctrine of equivalents apply to patent infringement? A: The doctrine of equivalents allows for infringement to be found if the accused product performs substantially the same function in substantially the same way to achieve substantially the same result as the claimed invention.

Q: What is the purpose of the Patent Claims Research Dataset? A: The dataset provides detailed information on claims from U.S. patents, helping in analyzing the scope and coverage of patents.

Q: How can a Claim Coverage Matrix be useful in patent management? A: A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.

Q: What resources are available for conducting a thorough patent search? A: Resources include the USPTO's Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs).

Sources

  1. Bio-Technology General v. Duramed Pharmaceuticals, 174 F. Supp. 2d 229 (2001)
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States
  3. Patent Claims Research Dataset, United States Patent and Trademark Office
  4. Search for patents, United States Patent and Trademark Office
  5. Patent Analytics, Schwegman, Lundberg & Woessner, P.A.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,921,843

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,921,843

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 175353 ⤷  Subscribe
Australia 4497089 ⤷  Subscribe
Australia 620940 ⤷  Subscribe
Canada 2001144 ⤷  Subscribe
Germany 68928897 ⤷  Subscribe
European Patent Office 0397823 ⤷  Subscribe
Finland 103951 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.